Altres autors/es

Institut Català de la Salut

[Lau L] Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. [Baddour L] Departments of Medicine and Cardiovascular Medicine, Division of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN, USA. [Fernández Hidalgo N] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain. CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. [Brothers TD] Division of General Internal Medicine, Dalhousie University, Halifax, Nova Scotia, Canada. Addiction Medicine Consult Service, Queen Elizabeth II Health Sciences Centre, Nova Scotia Health, Halifax, Nova Scotia, Canada. [Kong WKF] Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore. [Borger MA] Leipzig Heart Center, University of Leipzig, Leipzig, Germany

Vall d'Hebron Barcelona Hospital Campus

Data de publicació

2025-07-08T10:57:40Z

2025-07-08T10:57:40Z

2025-06-21



Resum

Infective endocarditis; Multidisciplinary; Team


Endocarditis infecciosa; Multidisciplinari; Equip


Endocarditis infecciosa; Multidisciplinario; Equipo


Infective endocarditis (IE) is a relatively rare but life-threatening systemic infection, which remains associated with high morbidity and mortality. The epidemiology of IE has shifted to involve an increasing numbers of older patients with both cardiovascular and other types of prosthetic devices, multiple comorbid conditions often requiring invasive procedures, increasingly virulent pathogens, in particular Staphylococcus aureus, or that can harbour anti-microbial resistance, and an escalation of injection drug use in many areas of the world. In parallel, advancements in diagnostic and therapeutic options have led to complex strategies in patients’ management. Despite these epidemiologic shifts, clinical trials have been rare and most of the evidence guiding IE management derives from expert consensus or analysis of large registries. Because of this, a multi-disciplinary IE team-based approach has been recommended as the standard of care. The aim of this review is to explore the rationale for a multi-disciplinary team-based approach to the management of IE. This approach has proved to be potentially beneficial based on multiple investigations that have evaluated patient outcomes. In addition, implementation strategies, feasibility and options of the team approach have also been highlighted.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

Oxford University Press

Documents relacionats

European Heart Journal;46(24)

https://doi.org/10.1093/eurheartj/ehaf219

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)